发明名称 Methods of therapeutic monitoring of nitrogen scavenging drugs
摘要 The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitrogen scavenging drug, determine whether to administer a nitrogen scavenging drug, and treat nitrogen retention disorders.
申请公布号 US9254278(B2) 申请公布日期 2016.02.09
申请号 US201514816674 申请日期 2015.08.03
申请人 Horizon Therapeutics, Inc. 发明人 Scharschmidt Bruce;Mokhtarani Masoud
分类号 A61K49/00;A61P13/00;A61K31/216;A61K9/00;G01N31/22;G01N33/49 主分类号 A61K49/00
代理机构 代理人
主权项 1. A method of treating a subject with a urea cycle disorder, the method comprising: administering to the subject in need thereof glyceryl tri-[4-phenylbutyrate] in an amount sufficient to produce a fasting plasma ammonia level that is less than half the upper limit of normal for plasma ammonia level.
地址 Deerfield IL US